Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/1998
11/12/1998WO1998050558A2 Production of ascorbic acid in plants
11/12/1998WO1998050557A1 Proteins involved in the synthesis and assembly of core lipopolysaccharide of pseudomonas aeruginosa
11/12/1998WO1998050556A2 Intracellular production of hepatitis c e1 and e2 truncated polypeptides
11/12/1998WO1998050555A2 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998WO1998050554A2 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998WO1998050553A1 Starch biosynthetic enzymes
11/12/1998WO1998050552A1 Novel tumor antigens
11/12/1998WO1998050551A1 Rage1-like protein
11/12/1998WO1998050550A1 Human translocation associated protein
11/12/1998WO1998050549A2 Two human g-protein coupled receptors: ebv-induced gpcr 2 (ebi-2) and edg-1-like gpcr
11/12/1998WO1998050548A1 New vesicle trafficking protein
11/12/1998WO1998050547A2 Human toll-like receptor proteins, related reagents and methods
11/12/1998WO1998050546A2 B cell receptor associated proteins
11/12/1998WO1998050545A1 Human smt-3 like protein
11/12/1998WO1998050544A1 Recombinant fragments of the human acetylcholine receptor and their use for treatment of myasthenia gravis
11/12/1998WO1998050543A1 Recombinant lactoferrin, methods of production from plants and uses
11/12/1998WO1998050542A1 Uncoupling protein homologue: ucp 3
11/12/1998WO1998050541A1 Methods and compositions to facilitate d-loop formation by oligonucleotides
11/12/1998WO1998050540A1 MODIFIED ANTISENSE NUCLEOTIDES COMPLEMENTARY TO A SECTION OF THE HUMAN Ha-Ras GENE
11/12/1998WO1998050539A2 Gene targeting and sibling-selection to generate mutant individuals
11/12/1998WO1998050535A1 Transgenic mice expressing hiv-1 in immune cells
11/12/1998WO1998050532A2 A process for preparing an anti-oxidant
11/12/1998WO1998050531A1 Nucleic acid molecules specific for bacterial antigens and uses thereof
11/12/1998WO1998050530A2 Enzymatic nucleic acids: synthesis, selection and use
11/12/1998WO1998050529A1 Attenuation of negative stranded rna viruses by rearrangement of their genes and uses thereof
11/12/1998WO1998050528A1 Isolated nucleic acid molecules encoding ssx family members and uses thereof
11/12/1998WO1998050524A1 Single zymomonas mobilis strain for xylose and arabinose fermentation
11/12/1998WO1998050513A1 Laundry and cleaning compositions containing xyloglucanase enzymes
11/12/1998WO1998050435A1 Immunotoxins, comprising an onc protein, directed against malignant cells
11/12/1998WO1998050434A1 Methods for eosinophil depletion and compositions therefor
11/12/1998WO1998050433A2 Human monoclonal antibodies to epidermal growth factor receptor
11/12/1998WO1998050432A1 Recombinant antibody-enzyme fusion proteins
11/12/1998WO1998050431A2 A method for making multispecific antibodies having heteromultimeric and common components
11/12/1998WO1998050430A2 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging
11/12/1998WO1998050426A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
11/12/1998WO1998050424A2 Human serine protease precursor
11/12/1998WO1998050408A1 Hybrid ribozymes and methods of use
11/12/1998WO1998050407A1 Eukaryotic and retroviral antisense initiator elements
11/12/1998WO1998050406A1 Cell proliferation related genes
11/12/1998WO1998050405A1 An infectious clone for human parainfluenza virus type 3
11/12/1998WO1998050403A1 Target-dependent reactions using structure-bridging oligonucleotides
11/12/1998WO1998050402A1 Dna molecule conferring on mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates
11/12/1998WO1998050401A1 Method for detecting the presence of biological matters of bovine origin, and oligonucleotides for its implementation
11/12/1998WO1998050397A2 Chimeric oligonucleotides and the use thereof
11/12/1998WO1998050081A2 In vivo expression system for cellular receptors
11/12/1998WO1998050079A2 Techniques and compositions for treating heart failure and ventricular remodeling by in vivo delivery of angiogenic transgenes
11/12/1998WO1998050073A1 Integrin ligand, human mindin
11/12/1998WO1998050069A1 Recombinant feline herpesvirus comprising a foreign dna inserted into a feline herpesvirus genome
11/12/1998WO1998050058A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998WO1998050057A2 Agent for enhancing the heart force
11/12/1998WO1998050053A1 Gene transfer with adenoviruses having modified fiber proteins
11/12/1998WO1998049888A1 Transgenic seedless fruit and methods
11/12/1998WO1998045437A3 Secreted expressed sequence tags (sests)
11/12/1998WO1998045436A3 Secreted expressed sequence tags (sests)
11/12/1998WO1998045435A3 Secreted expressed sequence tags (sests)
11/12/1998WO1998036074A3 Single and double chain antibodies to the egf receptor, derivates thereof and their use
11/12/1998WO1998036061A3 Reducing fibrosis and/or scarring by inhibiting interleukin-6 receptor-mediated activity
11/12/1998WO1998032864A3 Novel lipid kinase
11/12/1998WO1998032862A3 L-alanine dehydrogenase of mycobacterium marinum
11/12/1998WO1998032858A3 Mammalian chemokines; receptors; reagents; uses
11/12/1998WO1998032846A3 Enzymatic nucleic acid treatment of diseases or conditions related to levels of c-fos
11/12/1998WO1998031806A3 Fc receptors and polypeptides
11/12/1998WO1998031707A3 Transgenic animals with disrupted npy y1 receptor genes
11/12/1998WO1998030695A3 Secreted proteins and polynucleotides encoding them
11/12/1998WO1998030694A3 TUMOR NECROSIS FACTOR RECEPTORS 6α AND 6$g(b)
11/12/1998WO1998029744A3 Method to classify gene products
11/12/1998WO1998029540A3 RECOMBINANT FUSION PROTEINS BASED ON RIBOSOME-INACTIVATING PROTEINS OF EUROPEAN MISTLETOE $i(VISCUM ALBUM)
11/12/1998WO1998029539A3 Partial sequences of purine biosynthesis genes from ashbya gossypii and their use in the microbial riboflavin synthesis
11/12/1998WO1998028991A3 Cloudy fruit juices and methods for making same
11/12/1998WO1998023731A3 Chimeric target molecules having a regulatable activity
11/12/1998WO1998020162A3 Electrodes linked via conductive oligomers to nucleic acids
11/12/1998WO1998020030A3 Disruption of the mammalian rad51 protein and disruption of proteins that associate with mammalian rad51 for hindering cell proliferation
11/12/1998WO1998000533A3 Maize promoter sequence for leaf- and stalk-preferred gene expression
11/12/1998WO1997039128A3 Use of a modified rev-responsive element (rre) in methods and compositions for combatting hiv infection
11/12/1998CA2703181A1 Prrsv antigenic sites identifying peptide sequences of prrs virus for use in vaccines or diagnostic assays
11/12/1998CA2299455A1 Complex formation between dsdna and oligomer of heterocycles
11/12/1998CA2290064A1 Laundry and cleaning compositions containing xyloglucanase enzymes
11/12/1998CA2289878A1 Proteins involved in the synthesis and assembly of core lipopolysaccharide of pseudomonas aeruginosa
11/12/1998CA2289869A1 Transgenic seedless fruit and methods
11/12/1998CA2289613A1 In vivo expression system for cellular receptors
11/12/1998CA2289236A1 Transgenic mice expressing hiv-1 in immune cells
11/12/1998CA2289235A1 Improved cloning vector containing marker inactivation system
11/12/1998CA2289215A1 Gene transfer with adenoviruses having modified fiber proteins
11/12/1998CA2289118A1 Novel tumor antigens
11/12/1998CA2289116A1 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998CA2289115A1 Recombinant antibody-enzyme fusion proteins
11/12/1998CA2289046A1 Human g-protein coupled receptors
11/12/1998CA2289025A1 Human serine protease precursor
11/12/1998CA2288946A1 Modified antisense nucleotides complementary to a section of the human ha-ras gene
11/12/1998CA2288944A1 Enterococcus faecalis polynucleotides and polypeptides
11/12/1998CA2288901A1 Uncoupling protein homologue: ucp 3
11/12/1998CA2288739A1 Production of ascorbic acid in plants
11/12/1998CA2288675A1 Human prohormone convertase 4
11/12/1998CA2288672A1 Regulating metabolism by modifying the level of trehalose-6-phosphate by inhibiting endogenous trehalase levels
11/12/1998CA2288640A1 Enzymatic nucleic acids: synthesis, selection and use
11/12/1998CA2288435A1 Recombinant lactoferrin, methods of production from plants and uses
11/12/1998CA2288374A1 Intracellular production of hepatitis c e1 and e2 truncated polypeptides
11/12/1998CA2288232A1 Immunotoxins directed against malignant cells
11/12/1998CA2288017A1 Methods for eosinophil depletion and compositions therefor
11/12/1998CA2287204A1 Methods of production of an amidated peptide through the use of a fusion protein
1 ... 3469 3470 3471 3472 3473 3474 3475 3476 3477 3478 3479 3480 3481 3482 3483 3484 3485 3486 3487 3488 3489 ... 4023